FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20540611000001105: Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1877201000001119 Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1877221000001114 Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Is a Sodium clodronate 800mg tablets 60 tablet true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has AMP Clasteon 800mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient Clodronate disodium true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Clasteon 800mg tablets (Kent Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start